Wenthe, J., Eriksson, E., Hellström, A. C., Moreno, R., Ullenhag, G., Alemany, R., . . . Loskog, A. (2023). Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models.

Wenthe, Jessica, Emma Eriksson, Ann Charlotte Hellström, Rafael Moreno, Gustav Ullenhag, Ramon Alemany, Tanja Lövgren, e Angelica Loskog. Immunostimulatory Gene Therapy Targeting CD40, 4-1BB and IL-2R Activates DCs and Stimulates Antigen-specific T-cell and NK-cell Responses in Melanoma Models. 2023.

Wenthe, Jessica, et al. Immunostimulatory Gene Therapy Targeting CD40, 4-1BB and IL-2R Activates DCs and Stimulates Antigen-specific T-cell and NK-cell Responses in Melanoma Models. 2023.